表紙
市場調查報告書
商品編碼
967193

研究用抗體及試劑的全球市場、COVID-19的影響 (∼2025年):各產品 (抗體、試劑)、技術 (西方印漬術、流式細胞技術)、用途 (蛋白質體學、醫藥品開發)、終端用戶、地區

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User-COVID-19 Impact-Global Forecast to 2025

出版日期: | 出版商: MarketsandMarkets | 英文 269 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

研究用抗體及試劑的市場規模在預測期間內預計以6.7%的年複合成長率發展,從2020年的1010億美元,2025年141億美元性規模成長。蛋白質體學及基因學研究的成長,研究的再現性用高品質抗體的需求高漲,生命科學部門的R&D活動及支出的增加等要素促進該市場的成長。還有受到個人化醫療,結構為基礎的藥物設計的需求高漲所推動,今後數年預計大幅度成長。

本報告提供全球研究用抗體及試劑的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,產品、技術、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 產業考察

  • 產業趨勢
  • 相關利益者分析
  • 策略性基準
  • COVID-19的影響

第7章 市場分析、預測:各產品

  • 試劑
    • 培養基、血清
    • 染色劑、染料
    • 固定液
    • 緩衝
    • 溶劑
    • 酵素
    • 探針
    • 其他
  • 抗體
    • 各類型
    • 各形態
    • 各原料
    • 各研究領域

第8章 市場分析、預測:各技術

  • 西方印漬術
  • 流式細胞技術
  • 酵素免疫分析法 (ELISA)
  • 免疫組織化學
  • 免疫螢光法
  • 免疫沉澱
  • 其他

第9章 市場分析、預測:各用途

  • 蛋白質體學
  • 醫藥品開發
  • 基因學

第10章 市場分析、預測:各終端用戶

  • 製藥、生物科技企業
  • 學術研究機關
  • CRO

第11章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 南美
  • 中東、非洲

第12章 競爭情形

  • 概要
  • 評估架構
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭情形、趨勢

第13章 企業簡介

  • THERMO FISHER SCIENTIFIC
  • MERCK GROUP
  • ABCAM PLC
  • BECTON, DICKINSON AND COMPANY
  • CELL SIGNALING TECHNOLOGY
  • BIO-RAD LABORATORIES
  • F. HOFFMANN-LA ROCHE
  • AGILENT TECHNOLOGIES
  • DANAHER CORPORATION
  • LONZA
  • GENSCRIPT
  • PERKINELMER
  • BIOLEGEND
  • ILLUMINA
  • IMMUNOPRECISE ANTIBODIES
  • FUJIREBIO DIAGNOSTICS AB
  • ANALYTIK JENA AG
  • OMEGA BIO-TEK
  • DOVETAIL GENOMICS
  • ATLAS ANTIBODIES

第14章 附錄

目錄
Product Code: BT 5482

The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

Based on product, the reagents segment holds the highest market share during the forecast period.

Based on product, the research antibodies and reagents market are segmented into reagent and antibodies. The reagent segment accounted for the larger market share in 2019. The reagents market is experiencing notable growth due to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields.

Based on technology, the flow cytometry segment is expected to register the highest CAGR during the forecast period.

Based technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. The flow cytometry segment is expected to witness the highest growth during the forecast period. This is mainly due to this technique is its ability to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture. It offers high throughput and the automated quantification of cell features. These factors, along with technological innovations in flow cytometry and growing cancer research, are driving the growth of this segment.

By application , the proteomics holds the highest market share during the forecast period.

Based on application, the research antibodies and reagents market is segmented into proteomics, drug development and Genomics. Proteomics held the largest share of the global research antibodies and reagents market in 2019.The growth of the segment is due to as it efficiently maps drug-protein and protein-protein interactions. Moreover, proteomic technologies have minimized the cost, time, and resource requirements for chemical synthesis and biological testing of drugs. Proteomic technologies, such as electrophoresis, ELISA, microarrays, and MS-based proteomics, are highly efficient for analytical laboratory testing.

By enduser , the pharmaceutical & biotechnology holds the highest market share during the forecast period.

The research antibodies and reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The pharmaceutical & biotechnology companies held the largest share of the global research antibodies and reagents end-user market in 2019. The large share of this segment is attributed to the wide use of research antibodies in drug development for the identification and quantification of biomarkers and various analytical procedures.

By Region, The Asia Pacific region is expected to register the highest CAGR during the forecast period.

The Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR from 2020 to 2025.The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45% and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the research antibodies and reagents market

The key players operating in the researsch antibodies and reagents systems include Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).

Research Coverage:

The report analyzes the research antibodies and reagent market and aims at estimating the market size and future growth potential of this market based on various segments such as product, distribution channel, and region. The report also includes a product portfolio matrix of various research antibodies and reagents products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global research antibodies and reagent market. The report analyzes this market by product and distribution channel.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global research antibodies and reagent market.
  • Market Development: Comprehensive information on the lucrative emerging markets by product and distribution channel
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global research antibodies and reagent market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global research antibodies and reagent market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 MARKET SIZING FROM COMPANY REVENUE
    • FIGURE 7 MARKET ANALYSIS APPROACH
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION APPROACH
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 RESEARCH ANTIBODIES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 RESEARCH REAGENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 13 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 14 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 15 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 16 GEOGRAPHIC ANALYSIS: RESEARCH ANTIBODIES AND REAGENTS MARKET

4 PREMIUM INSIGHTS

  • 4.1 RESEARCH ANTIBODIES AND REAGENTS: MARKET OVERVIEW
    • FIGURE 17 INCREASING R&D EXPENDITURE IN THE LIFE SCIENCE INDUSTRY TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION
    • FIGURE 18 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RESEARCH ANTIBODIES AND REAGENTS MARKET IN 2019
  • 4.3 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA SHOWS THE HIGHEST REVENUE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • 4.4 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION (2018-2025)
    • FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESEARCH ANTIBODIES AND REAGENTS MARKET UNTIL 2025
  • 4.5 RESEARCH ANTIBODIES AND REAGENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing research activity and funding for R&D
      • 5.2.1.2 Growing industry-academia collaboration
    • TABLE 1 KEY MARKET DRIVERS: IMPACT ANALYSIS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Quality concerns and a lack of reproducible results
    • TABLE 2 KEY MARKET RESTRAINTS: IMPACT ANALYSIS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Personalized medicine and protein therapeutics
    • FIGURE 23 NUMBER OF PERSONALIZED MEDICINE PRODUCTS, 2008-2016
      • 5.2.3.3 Growth in stem cell and neurobiology research
      • 5.2.3.4 Increasing focus on biomarker discovery
      • 5.2.3.5 Rising interest in outsourcing
    • TABLE 3 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Cost and time-intensive antibody development processes
      • 5.2.4.2 Pricing pressure faced by prominent market players
    • TABLE 4 KEY MARKET CHALLENGES: IMPACT ANALYSIS

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 INCREASING RESEARCH ON THERAPEUTIC ANTIBODIES
    • 6.2.2 RECOMBINANT ANTIBODIES ARE SUPPORTING THE SMOOTH TRANSITION FROM IN VITRO TO IN VIVO
    • 6.2.3 GROWING CONSOLIDATION OF THE LIFE SCIENCE ANTIBODIES AND REAGENTS MARKET
    • TABLE 5 MAJOR ACQUISITIONS IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET
  • 6.3 STAKEHOLDER ANALYSIS
    • FIGURE 24 RESEARCH ANTIBODIES AND REAGENTS MARKETS: STAKEHOLDER ANALYSIS (2019)
  • 6.4 STRATEGIC BENCHMARKING
    • TABLE 6 PRODUCT PORTFOLIO ANALYSIS
  • 6.5 IMPACT OF COVID-19 ON THE RESEARCH ANTIBODIES AND REAGENTS MARKET

7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 7.2 REAGENTS
    • TABLE 8 REAGENTS, BY TYPE
    • TABLE 9 RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 10 RESEARCH REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.1 MEDIA & SERA
      • 7.2.1.1 Media & sera hold the largest share of the reagents market
    • TABLE 11 RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.2 STAINS & DYES
      • 7.2.2.1 Growth of the life science industry is driving the demand and use of stains & dyes
    • TABLE 12 RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.3 FIXATIVES
      • 7.2.3.1 Fixative agents are needed to preserve the morphology and antigenicity of target molecules
    • TABLE 13 RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.4 BUFFERS
      • 7.2.4.1 Wide use in drug development will drive the market for buffers
    • TABLE 14 RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.5 SOLVENTS
      • 7.2.5.1 Organic solvents see wide use in pharmaceutical processes and assays like IHC
    • TABLE 15 RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.6 ENZYMES
      • 7.2.6.1 An increase in proteomic and genomic research activity will ensure demand for enzymes
    • TABLE 16 RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.7 PROBES
      • 7.2.7.1 The versatility, sensitivity, and quantitative capabilities of probes have ensured their use in research
    • TABLE 17 RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.8 OTHER REAGENTS
    • TABLE 18 OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 ANTIBODIES
    • TABLE 19 RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.3.1 ANTIBODIES, BY TYPE
    • TABLE 20 ANTIBODIES, BY TYPE
    • TABLE 21 RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • 7.3.1.1 Primary antibodies
        • 7.3.1.1.1 Increasing demand for accurate and reliable antibodies follows the rise in R&D activity and expenditure
    • TABLE 22 PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.1.2 Secondary antibodies
        • 7.3.1.2.1 Versatility and low cost of production have ensured stable growth in the market for secondary antibodies
    • TABLE 23 SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.3.2 ANTIBODIES, BY FORM
    • TABLE 24 ANTIBODIES, BY FORM
    • TABLE 25 RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
      • 7.3.2.1 Monoclonal antibodies
        • 7.3.2.1.1 Monoclonal antibodies are among the most common tools in biomedical science
    • TABLE 26 MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.2.2 Polyclonal antibodies
        • 7.3.2.2.1 Thermo Fisher Scientific and Abcam are major players in the polyclonal antibodies market
    • TABLE 27 POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.2.3 Recombinant antibodies
        • 7.3.2.3.1 Recombinant antibodies provide a high-specificity, high-sensitivity option
    • TABLE 28 RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.3.3 ANTIBODIES, BY SOURCE
    • TABLE 29 ANTIBODIES, BY SOURCE
    • TABLE 30 RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
      • 7.3.3.1 Mice
        • 7.3.3.1.1 Mice are the preferred hosts for research-use antibody production
    • TABLE 31 MOUSE ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.3.2 Rabbits
        • 7.3.3.2.1 Rabbits are a cost-effective means of antibody production
    • TABLE 32 RABBIT ANTIBODIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.3.3 Other sources
    • TABLE 33 OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.3.4 ANTIBODIES, BY RESEARCH AREA
    • TABLE 34 ANTIBODIES, BY RESEARCH AREA
    • TABLE 35 RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
      • 7.3.4.1 Oncology
        • 7.3.4.1.1 The high prevalence of cancer has boosted research activity in the sector
    • TABLE 36 RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.4.2 Infectious diseases
        • 7.3.4.2.1 Rising awareness and growing research activity are key drivers of the market
    • TABLE 37 RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.4.3 Immunology
        • 7.3.4.3.1 Antibodies are used to identify protein and peptides to understand infectious disease immunology better
    • TABLE 38 RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.4.4 Neurobiology
        • 7.3.4.4.1 Antibody-based approaches are widely used in molecular and cellular neuroscience
    • TABLE 39 RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.4.5 Stem cells
        • 7.3.4.5.1 Increasing funding and the growing importance of stem cells in transplantation are key market drivers
    • TABLE 40 RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2018-2025 (USD MILLION)
      • 7.3.4.6 Other research areas
    • TABLE 41 RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2018-2025 (USD MILLION)

8 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 42 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 8.2 WESTERN BLOTTING
    • 8.2.1 HIGH ACCURACY, EASE OF INTERPRETATION, AND OTHER ADVANTAGES HAVE PROPELLED THE USE OF WESTERN BLOTTING
    • TABLE 43 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.3 FLOW CYTOMETRY
    • 8.3.1 FLOW CYTOMETRY IS THE FASTEST-GROWING TECHNOLOGY SEGMENT OF THE MARKET
    • TABLE 44 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.4 ENZYME-LINKED IMMUNOSORBENT ASSAY
    • 8.4.1 ELISA HAS THE POTENTIAL TO SUPERSEDE THE CURRENT GOLD STANDARD FOR COVID-19 TESTING
    • TABLE 45 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.5 IMMUNOHISTOCHEMISTRY
    • 8.5.1 COMPLEXITIES OF IHC POSE CHALLENGES TO MARKET GROWTH
    • TABLE 46 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.6 IMMUNOFLUORESCENCE
    • 8.6.1 IMMUNOFLUORESCENCE HELPS DETERMINE SPECIFIC GENE EXPRESSIONS
    • TABLE 47 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.7 IMMUNOPRECIPITATION
    • 8.7.1 RESULTS OBTAINED BY IP CAN BE ANALYZED THROUGH OTHER TECHNOLOGIES
    • TABLE 48 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.8 OTHER TECHNOLOGIES
    • TABLE 49 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)

9 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 50 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 9.2 PROTEOMICS
    • 9.2.1 PROTEOMICS HOLDS THE LARGEST SHARE OF THE MARKET, BY APPLICATION
    • TABLE 51 TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS
    • TABLE 52 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.3 DRUG DEVELOPMENT
    • 9.3.1 THE DRUG DEVELOPMENT APPLICATIONS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE
    • FIGURE 25 APPLICATION OF ANTIBODIES IN THE DRUG DEVELOPMENT PROCESS
    • TABLE 53 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.4 GENOMICS
    • 9.4.1 GENOMICS IS CURRENTLY AN EMERGING AREA OF RESEARCH APPLICATIONS AND EXPECTED TO SEE GROWTH IN THE COMING YEARS
    • TABLE 54 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2018-2025 (USD MILLION)

10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 55 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 PHARMA & BIOTECH COMPANIES DOMINATE THE END-USER MARKET
    • TABLE 56 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 10.3 ACADEMIC & RESEARCH INSTITUTIONS
    • 10.3.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL THE MARKET
    • TABLE 57 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 10.4 CONTRACT RESEARCH ORGANIZATIONS
    • 10.4.1 GROWING WORK ON MONOCLONAL ANTIBODIES AND DRUG CONJUGATES AMONG CROS IS AIDING MARKET GROWTH
    • TABLE 58 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

11 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • FIGURE 26 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SNAPSHOT (2019)
    • TABLE 59 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
    • TABLE 60 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 61 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 62 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 63 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 64 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 65 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 66 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 67 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 68 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 69 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 The US dominates the North American market in terms of market share
    • TABLE 70 US NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION)
    • TABLE 71 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 72 US: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 73 US: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 74 US: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 75 US: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 76 US: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 77 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 78 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 79 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Rising cancer incidence and a favorable funding scenario will push market growth in Canada
    • TABLE 80 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 81 CANADA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 CANADA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 84 CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 85 CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 86 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 87 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 88 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 28 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
    • TABLE 89 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 90 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 91 EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 94 EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 95 EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 96 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 97 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 98 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 German holds the largest share of the market in Europe
    • TABLE 99 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 100 GERMANY: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 101 GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 GERMANY: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 103 GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 104 GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 105 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 106 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 107 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 The market in the UK is characterized by expansions by leading players and growing R&D investments
    • TABLE 108 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 109 UK: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 110 UK: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 111 UK: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 112 UK: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 113 UK: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 114 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 115 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 116 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018 -2025 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Infrastructural development and rising research activity support market growth in France
    • TABLE 117 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 118 FRANCE: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 119 FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 120 FRANCE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 121 FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 122 FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 123 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 124 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 125 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Rising life science R&D and favorable funding scenario are key drivers of the Italian market
    • TABLE 126 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 127 ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 128 ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 129 ITALY: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 130 ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 131 ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 132 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 133 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 134 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Favorable scenario for research initiatives drives the market in Spain
    • TABLE 135 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 136 SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 138 SPAIN: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 139 SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 140 SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 141 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 142 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 143 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 144 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 145 REST OF EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 147 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 148 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 149 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 150 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 151 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 152 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
    • TABLE 153 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Japan dominates the APAC market
    • TABLE 163 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 164 JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 166 JAPAN: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 167 JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 168 JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 169 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 170 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 171 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 China is the fastest-growing segment of the overall market
    • TABLE 172 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 173 CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 CHINA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 176 CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 177 CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 178 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 179 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 180 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Strong economic growth and rising demand for pharmaceuticals are key market drivers in India
    • TABLE 181 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 182 INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 183 INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 184 INDIA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 185 INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 186 INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 187 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 188 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 189 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 11.4.4 REST OF ASIA PACIFIC
    • TABLE 190 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 191 ROAPAC: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 192 ROAPAC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 193 ROAPAC: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 194 ROAPAC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 195 ROAPAC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 196 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 197 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 198 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL AND MEXICO TO GROW AT HIGH RATES IN THE LATAM MARKET
    • TABLE 199 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 200 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 201 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 202 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 203 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 204 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 205 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 206 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 207 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 MEA HOLDS THE SMALLEST SHARE OF THE MARKET BUT IS EXPECTED TO PROVIDE STRONG GROWTH OPPORTUNITIES
    • TABLE 208 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 209 MEA: RESEARCH REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 210 MEA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 211 MEA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018-2025 (USD MILLION)
    • TABLE 212 MEA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018-2025 (USD MILLION)
    • TABLE 213 MEA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018-2025 (USD MILLION)
    • TABLE 214 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 215 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 216 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 MATRIX EVALUATION FRAMEWORK
    • FIGURE 30 MATRIX EVALUATION FRAMEWORK: ACQUISITION WAS THE MOST-ADOPTED STRATEGY
  • 12.3 RESEARCH ANTIBODIES MARKET SHARE ANALYSIS
    • FIGURE 31 GLOBAL RESEARCH ANTIBODIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 STARS
    • 12.4.2 EMERGING LEADERS
    • 12.4.3 PERVASIVE COMPANIES
    • 12.4.4 EMERGING COMPANIES
    • FIGURE 32 COMPETITIVE LEADERSHIP MAPPING (2019)
  • 12.5 COMPETITIVE SITUATION AND TRENDS
    • 12.5.1 PRODUCT LAUNCHES
    • TABLE 217 KEY PRODUCT LAUNCHES, 2020
    • 12.5.2 EXPANSIONS
    • TABLE 218 KEY EXPANSIONS, 2018-2020
    • 12.5.3 ACQUISITIONS
    • TABLE 219 KEY ACQUISITIONS, 2019-2020
    • 12.5.4 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
    • TABLE 220 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2019-2020

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)**

  • 13.1 THERMO FISHER SCIENTIFIC
    • FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • 13.2 MERCK GROUP
    • FIGURE 34 MERCK GROUP: COMPANY SNAPSHOT (2019)
  • 13.3 ABCAM PLC
    • FIGURE 35 ABCAM PLC: COMPANY SNAPSHOT (2019)
  • 13.4 BECTON, DICKINSON AND COMPANY
    • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
  • 13.5 CELL SIGNALING TECHNOLOGY
  • 13.6 BIO-RAD LABORATORIES
    • FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
  • 13.7 F. HOFFMANN-LA ROCHE
    • FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019)
  • 13.8 AGILENT TECHNOLOGIES
    • FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
  • 13.9 DANAHER CORPORATION
    • FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
  • 13.10 LONZA
    • FIGURE 41 LONZA: COMPANY SNAPSHOT (2019)
  • 13.11 GENSCRIPT
    • FIGURE 42 GENSCRIPT: COMPANY SNAPSHOT (2019)
  • 13.12 PERKINELMER
    • FIGURE 43 PERKINELMER: COMPANY SNAPSHOT (2019)
  • 13.13 BIOLEGEND
  • 13.14 ILLUMINA
    • FIGURE 44 ILLUMINA: COMPANY SNAPSHOT (2019)
  • 13.15 IMMUNOPRECISE ANTIBODIES
    • FIGURE 45 IMMUNOPRECISE ANTIBODIES: COMPANY SNAPSHOT (2019)
  • 13.16 FUJIREBIO DIAGNOSTICS AB
  • 13.17 ANALYTIK JENA AG
  • 13.18 OMEGA BIO-TEK
  • 13.19 DOVETAIL GENOMICS
  • 13.20 ATLAS ANTIBODIES

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 AVAILABLE CUSTOMIZATIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS